| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 07/09/2009 | US20090175948 Aerosol method for nano silver-silica composite anti-microbial agent |
| 07/09/2009 | US20090175945 Systems, Methods, and Formulations for Topically Treating Nail Fungal Infections and Nail Psoriasis |
| 07/09/2009 | US20090175928 Lip Plaster |
| 07/09/2009 | US20090175912 chimeric proteins; immunogens; from non-typeable Haemophilus influenzae or Moraxella catarrhalis, provides protective antigens in single molecule; inserting into surface exposed loops improves detection by immune system |
| 07/09/2009 | US20090175910 Modifications of HIV Env, Gag, and Pol enhance immunogenicity for genetic immunization |
| 07/09/2009 | US20090175909 Influenza Hemagglutinin And Neuraminidase Variants |
| 07/09/2009 | US20090175908 Influenza Hemagglutinin And Neuraminidase Variants |
| 07/09/2009 | US20090175907 Multi Plasmid System For The Production Of Influenza Virus |
| 07/09/2009 | US20090175904 Expressing hepatitis B virus surface antigen for vaccine preparation |
| 07/09/2009 | US20090175903 Measles subunit vaccine |
| 07/09/2009 | US20090175901 Immunostimulatory recombinant intracellular pathogen immunogenic compositions and methods of use |
| 07/09/2009 | US20090175898 Influenza Hemagglutinin And Neuraminidase Variants |
| 07/09/2009 | US20090175893 Albumin-Fused Anti-Angiogenesis Peptides |
| 07/09/2009 | US20090175883 Stabilized anti-respiratory syncytial virus (RSV) antibody formulations |
| 07/09/2009 | US20090175843 Composition for prevention or treatment of urinary tract infection |
| 07/09/2009 | US20090175827 miR-16 REGULATED GENES AND PATHWAYS AS TARGETS FOR THERAPEUTIC INTERVENTION |
| 07/09/2009 | US20090175824 Peptides for the treatment of HCV infections |
| 07/09/2009 | US20090175822 C5-substituted, proline-derived, macrocyclic hepatitis c serine protease inhibitors |
| 07/09/2009 | US20090175818 Poly(Potassium and Sodium Styrene Sulfonate) Its Manufacture and Its Uses |
| 07/09/2009 | US20090175810 Compositions and methods for treating diseases of the nail |
| 07/09/2009 | US20090175800 Methods and Compositions For P2X Receptor Calcium Entry Channels and Other Calcium Entry Mechanisms |
| 07/09/2009 | CA2711424A1 Novel lupane derivatives |
| 07/09/2009 | CA2711420A1 Novel c-21-keto lupane derivatives preparation and use thereof |
| 07/09/2009 | CA2710970A1 2-methylene-(20s,25r)-19,26-dinor-vitamin d analogs |
| 07/09/2009 | CA2710959A1 Imidazole carbonyl compounds and use thereof for treating bacterial infections |
| 07/09/2009 | CA2710786A1 Heterocyclic ring and phosphonoxymethyl group substituted pyridine derivatives, and antifungal agents containing same |
| 07/09/2009 | CA2704283A1 Vaccine |
| 07/09/2009 | CA2701991A1 Cyclic peptides comprising at least one aza-.beta.3-aminoacyl residue and uses thereof |
| 07/08/2009 | EP2077268A1 Process for preparing inhibitors of nucleoside metabolism |
| 07/08/2009 | EP2077260A1 Amide compound or salt thereof, and biofilm formation inhibitor, biofilm remover and bactericide each using the amide compound or salt thereof |
| 07/08/2009 | EP2077109A1 Amide compound, salt thereof, and biofilm remover using them |
| 07/08/2009 | EP2076596A1 Novel peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity |
| 07/08/2009 | EP2076529A1 Antibacterial and antiviral peptides from actinomadura namibiensis |
| 07/08/2009 | EP2076519A2 Novel dithiolopyrrolones and their therapeutical applications |
| 07/08/2009 | EP2076492A2 Non-nucleoside reverse transcriptase inhibitors |
| 07/08/2009 | EP2076278A2 Hcv ns3 protease inhibitors |
| 07/08/2009 | EP2076126A1 Novel combinations of dnak inhibitors with known antibacterial agents |
| 07/08/2009 | EP1592686B1 Gyrase inhibitors and uses thereof |
| 07/08/2009 | EP1435918B1 Highly compressible ethylcellulose for tableting |
| 07/08/2009 | EP1383927B1 New polynucleotides and polypeptides of the erythropoietin gene |
| 07/08/2009 | EP1371730B1 Recombinant poxvirus for chimeric proteins of the human immunodeficiency virus |
| 07/08/2009 | CN100510068C A soluble complex comprising a retroviral surface glycoprotein |
| 07/08/2009 | CN100510060C Method of extended culture for antigen-specific cytotoxic t lymphocytes |
| 07/08/2009 | CN100509846C Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 07/08/2009 | CN100509843C Acid-modified arabinogalactan protein composition |
| 07/08/2009 | CN100509833C Macrolides with antibacterial activity |
| 07/08/2009 | CN100509810C Substituted beta-carbolines |
| 07/08/2009 | CN100509805C 3,4-dihydro-1h-isoquinoloin-2-yl-derivatives |
| 07/08/2009 | CN100509801C HIV inhibiting pyrimidines derivatives |
| 07/08/2009 | CN100509797C Thiophene derivatives used as antiviral agent against flavivirus infections |
| 07/08/2009 | CN100509773C Alpha -amino-n-hydroxy-acetamide derivatives |
| 07/08/2009 | CN100509056C Vaccines including as an adjuvant type 1 IFN and process related thereto |
| 07/08/2009 | CN100509047C Combination of medication for treating hepatitis B and preparation method thereof |
| 07/08/2009 | CN100509008C Shutongfang for killing pain and preparation and use thereof |
| 07/08/2009 | CN100508990C Acrochordon alleviation |
| 07/08/2009 | CN100508978C Substituted 8-arylquinoline phosphodiesterase-4 inhibitors |
| 07/08/2009 | CN100508965C Dosage forms having prolonged active ingredient release |
| 07/07/2009 | US7557125 Fab I inhibitors |
| 07/07/2009 | US7557116 Substance which exhibits antiviral and antibacterial activity and is based on derivatives of 2,8-dithioxo-1H-pyrano[2,3d 6,5-d′]dipyrimidyne and 10-aza-analogue thereof |
| 07/07/2009 | US7556957 Attenuated virus-like particle for use as gene transfer tool in treatment and prevention of metabolic disorders; tissue target therapy |
| 07/07/2009 | US7556948 Method for producing crystallized pleuromutilins |
| 07/07/2009 | US7556940 Assembly of wild-type and chimeric influenza virus-like particles (VLPs) |
| 07/07/2009 | US7556812 Purified polypeptide used for eliciting immune response against a West Nile virus associated disease |
| 07/07/2009 | CA2486101C Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 07/07/2009 | CA2450033C Viral polymerase inhibitors |
| 07/07/2009 | CA2378834C Pyrazinones, compositions containing such compounds |
| 07/07/2009 | CA2304255C Hepatitis b virus polypeptides |
| 07/03/2009 | CA2648406A1 Translocator component derivatives and uses thereof |
| 07/03/2009 | CA2618278A1 Ipac derivatives and uses thereof |
| 07/02/2009 | WO2009082363A1 Method and preparations for treating infection-allergic diseases |
| 07/02/2009 | WO2009082267A1 MEDICINAL AGENT FOR ANTI-Helicobacter THERAPY |
| 07/02/2009 | WO2009081970A1 Process for production of heterocycle-substituted pyridine derivative |
| 07/02/2009 | WO2009081958A1 Glycosylated glycopeptide antibiotic derivative |
| 07/02/2009 | WO2009081955A1 Component protein pa1698 for type-iii secretion system of pseudomonas aeruginosa |
| 07/02/2009 | WO2009081789A1 Sulfonyl substituted 6-membered ring derivative |
| 07/02/2009 | WO2009081751A1 Novel method for producing antibiotic preparation |
| 07/02/2009 | WO2009081611A1 Antibacterial agent and composition for the oral cavity, food and drink containing the same |
| 07/02/2009 | WO2009081152A2 Antimicrobial compounds |
| 07/02/2009 | WO2009081117A1 Antibacterial combination therapy for the treatment of gram positive bacterial infections |
| 07/02/2009 | WO2009080836A2 Macrocyclic indoles as hepatitis c virus inhibitors |
| 07/02/2009 | WO2009080767A1 Fish vaccine |
| 07/02/2009 | WO2009080534A1 Heterocyclic antiviral compounds |
| 07/02/2009 | WO2009080432A2 Composition for treatment of tuberculosis |
| 07/02/2009 | WO2009079877A1 The dermatological compound preparation for oxidative stress interference period |
| 07/02/2009 | WO2009079837A1 A pharmaceutical formulation containing recombinant human serum albumin-interferon alpha fusion protein |
| 07/02/2009 | WO2009079834A1 An anti-hcv vaccine and preparation methods and uses thereof |
| 07/02/2009 | WO2009079822A1 A bcg polysaccharide nucleic acid extractive and preparation method thereof |
| 07/02/2009 | WO2009079796A1 Recombinant rsv antigens |
| 07/02/2009 | WO2009063221A3 Methods of treating or preventing inflammatory diseases of the intestinal tract |
| 07/02/2009 | WO2009046832A3 Short peptides used in medicine |
| 07/02/2009 | WO2009043176A9 Herbal compositions and methods for treating hepatic disorders |
| 07/02/2009 | WO2009033762A3 Use of endothelin-3 as a therapeutic agent |
| 07/02/2009 | WO2009033739A3 Use of a peptide as a therapeutic agent |
| 07/02/2009 | WO2009033678A3 Use of a tuftsin as a therapeutic agent |
| 07/02/2009 | WO2009001224A3 Antivirals |
| 07/02/2009 | WO2008137128A3 Methods of treating fungal infections |
| 07/02/2009 | US20090170953 Indentification of compounds that inhibit replication of human immunodeficiency virus |
| 07/02/2009 | US20090170941 Pharmaceutical Compounds |
| 07/02/2009 | US20090170931 EP2 and EP4 agonists as agents for the treatment of influenza a viral infection |
| 07/02/2009 | US20090170926 Antiviral agents |